Brief: Rosetta Genomics announces receipt of conditional approval
23/05/2016 13:04
May 23 (Reuters) - Rosetta Genomics Ltd ROSG.O
* Receipt of conditional approval from new york state
department of health for company's allele-specific pcr based
assays
Source text for Eikon: ID:nBw4B29jSa
Further company coverage: ROSG.O
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics